Literature DB >> 2556661

Calcitonin gene-related peptide-alpha receptor binding sites in the gastrointestinal tract.

T S Gates1, R P Zimmerman, C R Mantyh, S R Vigna, P W Mantyh.   

Abstract

Calcitonin gene-related peptide-alpha (CGRP alpha) is a putative neurotransmitter in the brain and in peripheral tissues. Quantitative receptor autoradiography was used to localize and quantify the distribution of specific binding sites for radiolabeled human CGRP alpha in the canine gastrointestinal tract. The canine gastrointestinal tract was chosen as a model since it is similar in both size and structure to the human gastrointestinal tract. In the stomach CGRP alpha binding sites were localized to smooth muscle cells in the muscularis mucosa and muscularis externa, the smooth muscle and endothelium of medium and small arteries, neurons in the myenteric plexus, mucosal epithelial cells and the germinal centers of lymph nodules. In the intestines, the prominent cells types expressing CGRP alpha receptors were myenteric neurons and the germinal centers of lymph nodules. Since previous studies have demonstrated that CGRP-containing sensory neurons innervate the muscularis externa in the stomach and since CGRP alpha receptors are expressed by smooth muscle cells in the muscularis externa, these results suggest that sensory neurons may directly regulate gastric motility by releasing CGRP. In correlation with previous physiological data, the present study suggests that CGRP is involved in the regulation of a variety of gastrointestinal functions including gastric motility, mucosal ion transport, hemodynamics, digestive enzyme secretion, neuronal excitability, and the inflammatory and immune response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556661     DOI: 10.1016/0306-4522(89)90439-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Co-localization of TRPV1-expressing nerve fibers with calcitonin-gene-related peptide and substance P in fundus of rat stomach.

Authors:  Syunji Horie; Gregory J Michael; John V Priestley
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Role of endothelium and nitric oxide in modulating in vitro responses of colonic arterial and venous rings to vasodilatory neuropeptides in horses.

Authors:  Rustin M Moore; Steven A Sedrish; Earnestine P Holmes; Catherine E Koch; Changaram S Venugopal
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

3.  Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract.

Authors:  Graeme S Cottrell; Farzad Alemi; Jacob G Kirkland; Eileen F Grady; Carlos U Corvera; Aditi Bhargava
Journal:  Peptides       Date:  2012-03-30       Impact factor: 3.750

4.  Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis.

Authors:  P Di Sebastiano; F F di Mola; C Di Febbo; G Baccante; E Porreca; P Innocenti; H Friess; M W Büchler
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 5.  Immunity and pain in the eye: focus on the ocular surface.

Authors:  Romina Mayra Lasagni Vitar; Filippo Bonelli; Paolo Rama; Giulio Ferrari
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

6.  Role of spinal afferents and calcitonin gene-related peptide in the postoperative gastric ileus in anesthetized rats.

Authors:  T T Zittel; S N Reddy; V Plourde; H E Raybould
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

7.  Effect of CGRP antagonist, alpha-CGRP 8-37, on acid secretion in the dog.

Authors:  D C Lawson; C R Mantyh; T N Pappas
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 8.  Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide's Motor-Stimulating and Prosecretory Function in the Intestine.

Authors:  Peter Holzer; Ulrike Holzer-Petsche
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.